Search research articles
Contact Us
Filters
Showing results (201-210 of 488) with videos related to
Page
of 49
Sort By:
The American Review of Respiratory Disease
|
July 1, 1979
Eikenella corrodens and pulmonary infections
E J Goldstein, B D Kirby, S M Finegold
The Journal of Infectious Diseases
|
August 1, 1983
Failure to detect Clostridium difficile in foods
J S Oishi, M E Mulligan, S M Finegold
Journal of Clinical Microbiology
|
June 1, 1982
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions
W L George, R D Rolfe, S M Finegold
Antimicrobial Agents and Chemotherapy
|
February 1, 1984
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria
H Wexler, W T Carter, B Harris, et al.
Infectious Disease Clinics of North America
|
June 1, 1993
Current perspectives on anaerobic infections: diagnostic approaches
S M Finegold, H R Jousimies-Somer, H M Wexler
International Journal of Food Sciences and Nutrition
|
July 15, 2015
In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp
Zhaoping Li, Paula H Summanen, Tomoe Komoriya, et al.
Journal of Clinical Microbiology
|
December 1, 1992
Cellular fatty acids in Fusobacterium species as a tool for identification
K Tunér, E J Baron, P Summanen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2001
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria
H M Wexler, E Molitoris, D Molitoris, et al.
FEMS Immunology and Medical Microbiology
|
March 1, 1993
The importance of black-pigmented gram-negative anaerobes in human infections
S M Finegold, C A Strong, M McTeague, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1994
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria
H M Wexler, E Molitoris, D Reeves, et al.
Page
of 49
Search research articles
Search
Showing results (201-210 of 488) with videos related to
Sort By:
Page
of 49
The American Review of Respiratory Disease
|
July 1, 1979
Eikenella corrodens and pulmonary infections
E J Goldstein, B D Kirby, S M Finegold
The Journal of Infectious Diseases
|
August 1, 1983
Failure to detect Clostridium difficile in foods
J S Oishi, M E Mulligan, S M Finegold
Journal of Clinical Microbiology
|
June 1, 1982
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions
W L George, R D Rolfe, S M Finegold
Antimicrobial Agents and Chemotherapy
|
February 1, 1984
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria
H Wexler, W T Carter, B Harris, et al.
Infectious Disease Clinics of North America
|
June 1, 1993
Current perspectives on anaerobic infections: diagnostic approaches
S M Finegold, H R Jousimies-Somer, H M Wexler
International Journal of Food Sciences and Nutrition
|
July 15, 2015
In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp
Zhaoping Li, Paula H Summanen, Tomoe Komoriya, et al.
Journal of Clinical Microbiology
|
December 1, 1992
Cellular fatty acids in Fusobacterium species as a tool for identification
K Tunér, E J Baron, P Summanen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2001
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria
H M Wexler, E Molitoris, D Molitoris, et al.
FEMS Immunology and Medical Microbiology
|
March 1, 1993
The importance of black-pigmented gram-negative anaerobes in human infections
S M Finegold, C A Strong, M McTeague, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1994
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria
H M Wexler, E Molitoris, D Reeves, et al.
Page
of 49